Speaker illustration

Doctor James Sheppard

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

I am a Population Health Scientist interested in better understanding the benefits and harms of treatments, with a particular focus on cardiovascular disease prevention. My research aims to develop tools which improve the targeting of preventative therapies such as antihypertensives and statins at patients with the most to gain. I lead the Stratified Treatments Research Group at the Nuffield Department of Primary Care Health Sciences at the University of Oxford. My group is interested in developing prognostic models for treatment harms using data from large electronic health record databases. In addition I am interested in developing new strategies to deal with polypharmacy and currently lead a randomised controlled trial of antihypertensive deprescribing in patients over the age of 80 years.

Do these data apply to me? Examining the applicability of trials assessing strategies for optimal management of blood pressure to older patients in UK primary care

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: Hypertension special circumstances

Thumbnail

An economic evaluation of using a clinical decision rule (PROOF-BP algorithm) in the diagnosis of hypertension in primary care

Event: ESC CONGRESS 2016

Topic: Ambulatory pressure monitoring

Session: Blood pressure variability and cardiovascular risk

Thumbnail

ESC 365 is supported by

logo Novo Nordisk